Page 83 - AN-1-2

Advanced Neurology NMDA receptors in neuropsychiatric diseases

paradigm for the preclinical evaluation of the stroke 269. Lason W, Turchan J, Przewłocki R, et al., 1997, Effects of
neuroprotectant Tat-NR2B9c in gyrencephalic nonhuman pilocarpine and kainate-induced seizures on N-methyl-D-
primates. Sci Transl Med, 4: 154ra133. aspartate receptor gene expression in the rat hippocampus.
Neuroscience, 78: 997–1004.
https://doi.org/1126/scitranslmed.3003824
https://doi.org/1016/s0306-4522(96)00635-5
260. Hill MD, Martin RH, Mikulis D, et al., 2012, Safety and
efficacy of NA-1 in patients with iatrogenic stroke after 270. Hosain S, Nagarajan L, Carson D, et al., 1997, Felbamate for
endovascular aneurysm repair (ENACT): A phase 2, refractory infantile spasms. J Child Neurol, 12: 466–468.
randomised, double-blind, placebo-controlled trial. Lancet https://doi.org/1177/088307389701200711
Neurol, 11: 942–950.
271. Zupanc ML, Werner RR, Schwabe MS, et al., 2010, Efficacy
https://doi.org/1016/S1474-4422(12)70225-9 of felbamate in the treatment of intractable pediatric
261. Beauchamp K, Mutlak H, Smith WR, et al., 2008, epilepsy. Pediatr Neurol, 42: 396–403.
Pharmacology of traumatic brain injury: Where is the https://doi.org/1016/j.pediatrneurol.2010.02.013
“golden bullet”? Mol Med, 14: 731–740.
272. McCabe RT, Wasterlain CG, Kucharczyk N, et al., 1993,
https://doi.org/2119/2008-00050.Beauchamp Evidence for anticonvulsant and neuroprotectant action
262. Biegon A, Fry PA, Paden CM, et al., 2004, Dynamic changes of felbamate mediated by strychnine-insensitive glycine
in N-methyl-D-aspartate receptors after closed head injury receptors. J Pharmacol Exp Ther, 264: 1248–1252.
in mice: Implications for treatment of neurological and 273. White HS, Harmsworth WL, Sofia RD, et al., 1995,
cognitive deficits. Proc Natl Acad Sci U S A, 101: 5117–5122. Felbamate modulates the strychnine-insensitive glycine
https://doi.org/1073/pnas.0305741101 receptor. Epilepsy Res, 20: 41–48.
263. Carter DS, Deshpande LS, Rafiq A, et al., 2011, https://doi.org/1016/0920-1211(94)00066-6
Characterization of spontaneous recurrent epileptiform 274. Rho JM, Donevan SD, Rogawski MA, 1994, Mechanism
discharges in hippocampal-entorhinal cortical slices of action of the anticonvulsant felbamate: opposing effects
prepared from chronic epileptic animals. Seizure, on N-methyl-D-aspartate and gamma-aminobutyric acidA
20: 218–224. receptors. Ann Neurol, 35: 229–234.
https://doi.org/1016/j.seizure.2010.11.022 https://doi.org/1002/ana.410350216
264. Meldrum BS, 1993, Excitotoxicity and selective neuronal 275. Singh L, Oles RJ, Vass CA, et al., 1991, A slow intravenous
loss in epilepsy. Brain Pathol, 3: 405–412. infusion of N-methyl-DL-aspartate as a seizure model in the
https://doi.org/1111/j.1750-3639.1993.tb00768.x mouse. J Neurosci Methods, 37: 227–232.
265. Jensen PJ, Millan N, Mack KJ, 1997, Cortical NMDAR-1 https://doi.org/1016/0165-0270(91)90028-x
gene expression is rapidly upregulated after seizure. Brain 276. Balosso S, Maroso M, Sanchez-Alavez M, et al., 2008, A novel
Res Mol Brain Res, 44: 157–162. non-transcriptional pathway mediates the proconvulsive
https://doi.org/1016/s0169-328x(96)00262-8 effects of interleukin-1beta. Brain, 131: 3256–3265.
266. Kikuchi S, Iwasa H, Sato T, 2000, Lasting changes in https://doi.org/1093/brain/awn271
NMDAR1 mRNA level in various regions of cerebral cortex 277. Yen W, Williamson J, Bertram EH, et al., 2004, A comparison
in epileptogenesis of amygdaloid-kindled rat. Psychiatry of three NMDA receptor antagonists in the treatment of
Clin Neurosci, 54: 573–577. prolonged status epilepticus. Epilepsy Res, 59: 43–50.
https://doi.org/1046/j.1440-1819.2000.00755.x https://doi.org/1016/j.eplepsyres.2004.03.004
267. Gerfin-Moser A, Grogg F, Rietschin L, et al., 1995, 278. Kleinrok Z, Turski WA, Czuczwar SJ, 1995, Excitatory
Alterations in glutamate but not GABAA receptor subunit amino acid antagonists and the anticonvulsive activity
expression as a consequence of epileptiform activity in vitro. of conventional antiepileptic drugs. Polish J Pharmacol,
Neuroscience, 67: 849-865. 47: 247–252.
https://doi.org/1016/0306-4522(95)00130-b 279. Brackett RL, Pouw B, Blyden JF, et al., 2000, Prevention
of cocaine-induced convulsions and lethality in mice:
268. Mathern GW, Pretorius JK, Leite JP, et al., 1998,
Hippocampal AMPA and NMDA mRNA levels and subunit Effectiveness of targeting different sites on the NMDA
immunoreactivity in human temporal lobe epilepsy patients receptor complex. Neuropharmacology, 39: 407–418.
and a rodent model of chronic mesial limbic epilepsy. https://doi.org/1016/s0028-3908(99)00151-3
Epilepsy Res, 32: 154–171.
280. Vataev SI, Zhabko EP, Lukomskaia N, et al., 2009, Effects of
https://doi.org/1016/s0920-1211(98)00048-5 memantine on convulsive reactions and sleep-waking cycle

Volume 1 Issue 2 (2022) 27 https://doi.org/10.36922/an.v1i2.148